85 related articles for article (PubMed ID: 2554479)
1. Carcinoembryonic antigen, arginine vasopressin and calcitonin as markers of early small-cell lung cancer relapse.
Biran H; Feld R; Sagman U; Rusthoven J; Shepherd FA; Evans WK; Ginsberg RJ; Panzarella T; Malkin A
Tumour Biol; 1989; 10(5):258-67. PubMed ID: 2554479
[TBL] [Abstract][Full Text] [Related]
2. Circulating arginine-vasopressin, calcitonin, carcinoembryonic antigen, neuron-specific enolase, and beta-2 microglobulin fluctuations during combined modality induction therapy for small-cell bronchogenic carcinoma. Association of postchemotherapy AVP surge with high tumor response rate and durable remission.
Biran H; Feld R; Malkin A
Tumour Biol; 1991; 12(3):131-7. PubMed ID: 1648782
[TBL] [Abstract][Full Text] [Related]
3. Is there any clinical relevance of serial determinations of serum carcinoembryonic antigen in small cell lung cancer patients?
Krischke W; Niederle N; Schütte J; Pfeiffer R; Hirche H
Cancer; 1988 Oct; 62(7):1348-54. PubMed ID: 2843279
[TBL] [Abstract][Full Text] [Related]
4. Carcinoembryonic antigen. A useful monitor of therapy of small cell lung cancer.
Goslin RH; Skarin AT; Zamcheck N
JAMA; 1981 Nov; 246(19):2173-6. PubMed ID: 6270390
[TBL] [Abstract][Full Text] [Related]
5. Carcinoembryonic antigen for monitoring patients with small cell carcinoma of the lung during treatment.
Waalkes TP; Abeloff MD; Woo KB; Ettinger DS; Ruddon RW; Aldenderfer P
Cancer Res; 1980 Dec; 40(12):4420-7. PubMed ID: 6254646
[TBL] [Abstract][Full Text] [Related]
6. [Serial measurements of serum carcinoembryonic antigen (CEA) and neuron-specific enolase (NSE) during chemotherapy of patients with inoperable lung cancer].
Fukuoka M; Takada M; Kamei T; Negoro S; Kusunoki Y; Matsui K; Ryu S; Sakai N; Takifuji N; Masuda N
Gan To Kagaku Ryoho; 1987 Mar; 14(3 Pt 2):871-80. PubMed ID: 3032108
[TBL] [Abstract][Full Text] [Related]
7. A study of immunoreactive calcitonin (CT), adrenocorticotropic hormone (ACTH) and carcinoembryonic antigen (CEA) in lung cancer and other malignancies.
Krauss S; Macy S; Ichiki AT
Cancer; 1981 May; 47(10):2485-92. PubMed ID: 6268270
[TBL] [Abstract][Full Text] [Related]
8. Use of carcinoembryonic antigen in small cell lung cancer. Prognostic value and relation to the clinical course 1.
Laberge F; Fritsche HA; Umsawasdi T; Carr DT; Welch S; Murphy WK; Chiuten DF; Dhingra HM; Farha P; Spitzer G
Cancer; 1987 Jun; 59(12):2047-52. PubMed ID: 3032400
[TBL] [Abstract][Full Text] [Related]
9. [Immunohistochemical detection of carcinoembryonic antigen and P-glycoprotein in small cell lung cancer at diagnosis and relapse, with special reference to the tissue expression of CEA and response to chemotherapy].
Ohnoshi T; Ueoka H; Segawa Y; Kiura K; Tabata M; Shibayama T; Maeda T; Miyatake K; Takigawa N; Kimura I
Nihon Kyobu Shikkan Gakkai Zasshi; 1992 Feb; 30(2):262-9. PubMed ID: 1351108
[TBL] [Abstract][Full Text] [Related]
10. [Clinical significance of serum carcinoembryonic antigen in small cell lung cancer patients].
Hino M; Ogasawara H; Yoshii A; Yoneda S; Noguchi Y; Sakai H; Yoshida K
Nihon Kyobu Shikkan Gakkai Zasshi; 1992 Feb; 30(2):278-84. PubMed ID: 1318435
[TBL] [Abstract][Full Text] [Related]
11. [Clinical significance of CEA levels in lung cancer].
Noge S; Hara N; Ichinose Y; Ishimatsu T; Motohiro A; Etoh K; Miyake J; Ohta M
Gan No Rinsho; 1985 May; 31(6 Suppl):616-22. PubMed ID: 2993691
[TBL] [Abstract][Full Text] [Related]
12. Non-small-cell lung cancer prognosis using carcinoembryonic antigen levels in pleural lavage fluid.
Tsutani Y; Yamashita Y; Misumi K; Ikeda T; Miyata Y; Okada M
Eur J Cardiothorac Surg; 2012 Nov; 42(5):e96-101. PubMed ID: 22906597
[TBL] [Abstract][Full Text] [Related]
13. Plasma calcitonin as a marker of disease activity in patients with small cell carcinoma of the lung.
Wallach SR; Royston I; Taetle R; Wohl H; Deftos LJ
J Clin Endocrinol Metab; 1981 Sep; 53(3):602-6. PubMed ID: 6267098
[TBL] [Abstract][Full Text] [Related]
14. Evaluation of the relationship between serum carcinoembryonic antigen level and treatment outcome in surgically resected clinical-stage I patients with non-small-cell lung cancer.
Hotta K; Segawa Y; Takigawa N; Kishino D; Saeki H; Nakata M; Mandai K; Eguchi K
Anticancer Res; 2000; 20(3B):2177-80. PubMed ID: 10928173
[TBL] [Abstract][Full Text] [Related]
15. Carcinoembryonic antigen: a useful prognostic marker in small-cell lung cancer.
Sculier JP; Feld R; Evans WK; Shepherd FA; DeBoer G; Malkin DG; Malkin A
J Clin Oncol; 1985 Oct; 3(10):1349-54. PubMed ID: 2995598
[TBL] [Abstract][Full Text] [Related]
16. [Biochemical methods and their place in prognosis and evaluation of the effectiveness of treatment of small cell lung cancer].
Bassalyk LS; Tkacheva GA; Ausekar BV; Smirnova KD; Gershteĭn ES
Vopr Onkol; 1985; 31(10):28-32. PubMed ID: 2998083
[TBL] [Abstract][Full Text] [Related]
17. Multiple biologic markers in the monitoring of treatment for patients with small cell carcinoma of the lung: the use of serial levels of plasma CEA and serum carbohydrates.
Woo KB; Waalkes P; Abeloff MD; Ettinger DS; McNitt KL; Gehrke CW
Cancer; 1981 Oct; 48(7):1633-42. PubMed ID: 6269720
[TBL] [Abstract][Full Text] [Related]
18. Prognostic value of pretreatment carcinoembryonic antigen after definitive radiotherapy with or without concurrent chemotherapy for squamous cell carcinoma of the uterine cervix.
Huang EY; Hsu HC; Sun LM; Chanchien CC; Lin H; Chen HC; Tseng CW; Ou YC; Chang HY; Fang FM; Huang YJ; Wang CY; Lu HM; Tsai CC; Ma YY; Fu HC; Wang YM; Wang CJ
Int J Radiat Oncol Biol Phys; 2011 Nov; 81(4):1105-13. PubMed ID: 20932670
[TBL] [Abstract][Full Text] [Related]
19. Preoperative serum carcinoembryonic antigen level as a predictive factor of recurrence after curative resection of colorectal cancer.
Takagawa R; Fujii S; Ohta M; Nagano Y; Kunisaki C; Yamagishi S; Osada S; Ichikawa Y; Shimada H
Ann Surg Oncol; 2008 Dec; 15(12):3433-9. PubMed ID: 18846401
[TBL] [Abstract][Full Text] [Related]
20. Optimal predictive value of preoperative serum carcinoembryonic antigen for surgical outcomes in stage I non-small cell lung cancer: differences according to histology and smoking status.
Kato T; Ishikawa K; Aragaki M; Sato M; Okamoto K; Ishibashi T; Oba K; Kaji M
J Surg Oncol; 2013 May; 107(6):619-24. PubMed ID: 23192365
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
